0000905148-24-000976.txt : 20240319 0000905148-24-000976.hdr.sgml : 20240319 20240319161227 ACCESSION NUMBER: 0000905148-24-000976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edmondson Frazor Titus III CENTRAL INDEX KEY: 0001835780 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 24763322 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR STREET 2: PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 form4.xml X0508 4 2024-03-15 0001704292 Zai Lab Ltd ZLAB 0001835780 Edmondson Frazor Titus III C/O ZAI LAB LIMITED 314 MAIN STREET, 4TH FLOOR, SUITE 100 CAMBRIDGE MA 02142 true Chief Legal Officer true American Depositary Shares 2024-03-15 4 S 0 10000 18.7127 D 20005 D Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023. Reflects a weighted average sale price of $18.7127 per share, at prices ranging from $18.40 to $19.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Bruce Blefeld, Attorney-in-Fact 2024-03-19